SARcode Bioscience Gets $44M
Brisbane-based SARcode Bioscience, a firm developing treatments for inflammatory disease, said this morning it has raised $44M in a Series B financing round. The round was led by Sofinnova Ventures, and also included Rho Ventures, Alta Partners, and Clarus Venture Partners. The firm said the funding goes towards clinical development of its product for "dry eye" syndrome, an inflammatory disease affecting approximately 20 million people in the U.S.
posted on Monday, July 18, 2011 (Link to more information)
Related companies:
SARcode
Related stories:
> SARcode Bioscience Acquired By Shire
> SARcode Gets Series A
> Twist Bioscience Buys Genome Compiler
> Crystal Bioscience Acquired By Ligand For Up To $30.5M
> Twist Bioscience Gets $37M
silicontap.com Home